BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1380 related articles for article (PubMed ID: 20055706)

  • 1. Metabotropic glutamate receptors: physiology, pharmacology, and disease.
    Niswender CM; Conn PJ
    Annu Rev Pharmacol Toxicol; 2010; 50():295-322. PubMed ID: 20055706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabotropic glutamate receptors for new treatments in schizophrenia.
    Herman EJ; Bubser M; Conn PJ; Jones CK
    Handb Exp Pharmacol; 2012; (213):297-365. PubMed ID: 23027420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive and negative allosteric modulation of metabotropic glutamate receptors: emerging therapeutic potential.
    Kew JN
    Pharmacol Ther; 2004 Dec; 104(3):233-44. PubMed ID: 15556676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics and modulation of metabotropic glutamate receptors.
    Rondard P; Pin JP
    Curr Opin Pharmacol; 2015 Feb; 20():95-101. PubMed ID: 25529199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabotropic glutamate receptor orthosteric ligands and their binding sites.
    Acher FC; Cabayé A; Eshak F; Goupil-Lamy A; Pin JP
    Neuropharmacology; 2022 Feb; 204():108886. PubMed ID: 34813860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Chronic Pain by Metabotropic Glutamate Receptors.
    Chiechio S
    Adv Pharmacol; 2016; 75():63-89. PubMed ID: 26920009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in positive allosteric modulators of metabotropic glutamate receptors.
    Shipe WD; Wolkenberg SE; Williams DL; Lindsley CW
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):449-57. PubMed ID: 16022181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabotropic glutamatergic receptors and their ligands in drug addiction.
    Pomierny-Chamioło L; Rup K; Pomierny B; Niedzielska E; Kalivas PW; Filip M
    Pharmacol Ther; 2014 Jun; 142(3):281-305. PubMed ID: 24362085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric modulation of metabotropic glutamate receptors.
    Sheffler DJ; Gregory KJ; Rook JM; Conn PJ
    Adv Pharmacol; 2011; 62():37-77. PubMed ID: 21907906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragment-Based Approaches for Allosteric Metabotropic Glutamate Receptor (mGluR) Modulators.
    Orgován Z; Ferenczy GG; Keserű GM
    Curr Top Med Chem; 2019; 19(19):1768-1781. PubMed ID: 31393248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropharmacological Insight from Allosteric Modulation of mGlu Receptors.
    Stansley BJ; Conn PJ
    Trends Pharmacol Sci; 2019 Apr; 40(4):240-252. PubMed ID: 30824180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group III metabotropic glutamate receptors: pharmacology, physiology and therapeutic potential.
    Mercier MS; Lodge D
    Neurochem Res; 2014 Oct; 39(10):1876-94. PubMed ID: 25146900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric Molecular Switches in Metabotropic Glutamate Receptors.
    Orgován Z; Ferenczy GG; Keserű GM
    ChemMedChem; 2021 Jan; 16(1):81-93. PubMed ID: 32686363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ionotropic and metabotropic glutamate receptor structure and pharmacology.
    Kew JN; Kemp JA
    Psychopharmacology (Berl); 2005 Apr; 179(1):4-29. PubMed ID: 15731895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of metabotropic glutamate receptor C-terminal domains in contact with interacting proteins.
    Enz R
    Front Mol Neurosci; 2012; 5():52. PubMed ID: 22536173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in the Modulation of Pain by the Metabotropic Glutamate Receptors.
    Mazzitelli M; Presto P; Antenucci N; Meltan S; Neugebauer V
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabotropic glutamate receptors: a review on prospectives and therapeutic aspects.
    Vaidya A; Jain S; Jain AK; Agrawal A; Kashaw SK; Jain SK; Agrawal RK
    Mini Rev Med Chem; 2013 Nov; 13(13):1967-81. PubMed ID: 22530579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabotropic glutamate receptors and neurodegenerative diseases.
    Ribeiro FM; Vieira LB; Pires RG; Olmo RP; Ferguson SS
    Pharmacol Res; 2017 Jan; 115():179-191. PubMed ID: 27872019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nociception modulation by supraspinal group III metabotropic glutamate receptors.
    Palazzo E; Marabese I; Luongo L; Guida F; de Novellis V; Maione S
    J Neurochem; 2017 May; 141(4):507-519. PubMed ID: 27363363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress toward advanced understanding of metabotropic glutamate receptors: structure, signaling and therapeutic indications.
    Yin S; Niswender CM
    Cell Signal; 2014 Oct; 26(10):2284-97. PubMed ID: 24793301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.